These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10318155)

  • 1. The impact of DRGs. Part II: After five years, coping comes naturally.
    Gore MJ
    MLO Med Lab Obs; 1988 Dec; 20(12):31-5. PubMed ID: 10318155
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of DRGs. Part I: A five-year overview.
    Gore MJ
    MLO Med Lab Obs; 1988 Dec; 20(12):26-30. PubMed ID: 10318154
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of DRGs after year 4. Part I: A swing to better times.
    Gore MJ
    MLO Med Lab Obs; 1987 Dec; 19(12):26-30. PubMed ID: 10312342
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of DRGs after year 2. Consolidating the changes; evaluating the tactics.
    Becker BL
    MLO Med Lab Obs; 1985 Dec; 17(12):26-32, 37-41. PubMed ID: 10317740
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of DRGs after year 1: management learns to cope. Part II.
    Becker BL
    MLO Med Lab Obs; 1984 Dec; 16(12):43-50. PubMed ID: 10317551
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of DRGs after year 3: Part II. How labs continue to cope.
    Hallam K
    MLO Med Lab Obs; 1986 Dec; 18(12):33-6. PubMed ID: 10311792
    [No Abstract]   [Full Text] [Related]  

  • 7. The rising trend in outpatient testing.
    Hallam K
    MLO Med Lab Obs; 1986 May; 18(5):24-8. PubMed ID: 10317745
    [No Abstract]   [Full Text] [Related]  

  • 8. Strategic planning for outreach laboratory services.
    Portugal B
    Pathologist; 1983 Aug; 37(8):537-40. PubMed ID: 10299324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of DRGs after year 4. Part II: Controlling expense, chasing revenue.
    Gore MJ
    MLO Med Lab Obs; 1987 Dec; 19(12):35-9. PubMed ID: 10312343
    [No Abstract]   [Full Text] [Related]  

  • 10. Economics of outreach testing in the hospital laboratory: Part II.
    Nigon DL
    Clin Lab Manage Rev; 1993; 7(5):414-8, 420-2. PubMed ID: 10128846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program, changes to the hospital outpatient prospective payment system and calendar year 2004 payment rates. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Nov; 68(216):63397-690. PubMed ID: 14610761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare outpatient prospective payment system.
    Gottlich V
    Issue Brief Cent Medicare Educ; 2003; 4(1):1-6. PubMed ID: 12635629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What's the point of cost management in clinical laboratories?].
    Setoyama T; Yamauchi K; Katsuyama T
    Rinsho Byori; 2006 Nov; 54(11):1127-35. PubMed ID: 17240834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physicians' view of the lab, Part 1. Clinicians examine the lab, and they like what they see.
    Jahn M
    MLO Med Lab Obs; 1997 Apr; 29(4):26-7, 30, 32-4. PubMed ID: 10172980
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lab regionalization: structural options for the age of managed competition. Part 2.
    Steiner JW; Root JM; Buck E
    MLO Med Lab Obs; 1994 Jul; 26(7):48-51. PubMed ID: 10171914
    [No Abstract]   [Full Text] [Related]  

  • 17. National survey results: automation is everywhere.
    Ringel M
    MLO Med Lab Obs; 1996 Dec; 28(12):38-43. PubMed ID: 10163263
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility scores for dimensions of clinical laboratory testing services from two purchaser perspectives.
    Otto CN
    Clin Leadersh Manag Rev; 2002; 16(2):70-6. PubMed ID: 11951542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New legislation gives hope for an improved Medicare payment system for clinical laboratory services.
    Pontius CA
    MLO Med Lab Obs; 2001 Sep; 33(9):50-1. PubMed ID: 11569129
    [No Abstract]   [Full Text] [Related]  

  • 20. Service basics attract new outpatient lab users.
    Hard R
    Hospitals; 1992 Feb; 66(4):70. PubMed ID: 1735551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.